Breakthrough in Fighting Fungal Pneumonia
Fungal pneumonia caused by Pneumocystis is difficult study, but scientists have developed a promising new model using precision-cut slices of lung tissue to allow lab cultures of the fungus.
Fungal pneumonia caused by Pneumocystis is difficult study, but scientists have developed a promising new model using precision-cut slices of lung tissue to allow lab cultures of the fungus.
Regular aerobic exercise is tied to a significantly lower risk of death from flu or pneumonia, even at levels below those recommended, according to a new study.
A cluster of pneumonia cases in Argentina was caused by legionella, the bacteria that causes Legionnaires' disease.
Even before the pandemic, an estimated 250,000-plus patients contracted VAP each year in the US, but effective strategies for infection control and ventilator management can reduce ventilator-associated pneumonia, as well as HAP and VAEs.
Read MoreA study published in the Annals of Intensive Care shows a 53% reduction of ventilator-associated pneumonia with Bactiguard’s endotracheal tube.
Read MorePfizer’s Prevnar 20 pneumococcal vaccine can be safely co-administered with the Pfizer-BioNTech COVID-19 vaccine, according to a Phase 3 study.
Read MoreThe European Commission approved Merck’s VaxNeuvance (Pneumococcal 15-valent Conjugate Vaccine) for prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae in individuals 18 years of age and older.
Read MoreResearchers in Sweden report that a recently discovered inflammatory mediator appears to have an important role in pneumonia and contribute to the killing of bacteria.
Read MoreA case study presented at Chest 2021 reports that the fungal infection coccidioidomycosis may have varied clinical presentations, including mimicking lung cancer.
Read MoreOnly 21% of patients with severe pneumonia caused by SARS-CoV-2 have a documented bacterial superinfection at the time of intubation, resulting in potential overuse of antibiotics.
Read MoreThe US FDA has approved Pfizer’s Prevnar 20 Pneumococcal 20-valent Conjugate Vaccine for the prevention of invasive disease and pneumonia in adults age 18 and older.
Read MoreThe American Thoracic Society released a new clinical practice guideline on community-acquired pneumonia.
Read MoreA history of pneumonia is the second-greatest overall risk factor for death from COVID-19, Harvard University researchers said.
Read MoreCOVID-19 pneumonia differs from non-COVID-19 pneumonia in the way that it colonizes areas of the lungs.
Read MoreCOVID-19 has forced many severely ill patients to undergo mechanical ventilation for extended durations, an intervention that can increase their risks of other hospital-acquired infections such as ventilator-associated pneumonia (VAP).
Read More